Navigation Links
Reduced Funds for Cancer is Cost of Iraq, Say Ex-White House Aide, Cancer Researchers
Date:4/18/2008

WASHINGTON, April 18 /PRNewswire-USNewswire/ -- An ex-White house aide, Robert Weiner, and Dr. Patricia Berg, director of a GWU Medical Center breast cancer lab, are reporting that many scientists believe that "the cost of the Iraq war is largely responsible for a drop in real dollars for cancer research, and private organizations, though critical, are a pale substitute for the power of the federal government." Discoveries are being lost due to "the high funding bar."

Weiner and Berg just returned from the annual national meeting of the American Association for Cancer Research (AACR), attended by 17,000 cancer researchers from throughout the U.S. and the world.

In a commentary in today's San Diego Union Tribune, "TOO FEW FUNDS TO FIGHT CANCER," Weiner and Berg report that "the underlying buzz all around the San Diego meeting was, Where is the Federal Government?"

They state, "physicians and researchers are making discoveries shattering the old death sentence of cancer -- the death rate has declined 2% a year since 2002. Still, 1500 Americans die a day from cancer, and one in two men and one in three women will develop cancer during their lives, according to new figures from CDC."

The authors contend, "It is tragic that private volunteer organizations have to scramble to pick up the pieces of the federal government, who with all its power, could be driving scientists closer to curing this dread disease."

NIH has lost 2% of its budget to inflation in real dollars every year for the last seven years, a 14% decline.

Weiner asked Ellen Sigal, Chairperson of Friends of Cancer Research in Arlington, VA, and the chair of a forum at AACR on alternative funding mechanisms, why there is the drop in federal funds. She responded, "We have a deficit and a war." Weiner argues, "If funding potential disease cures is the price of Iraq, it is no wonder that 70% of Americans oppose the war in the scheme of priorities."

NCI now funds fewer than 10% of requested research projects, down from 25% a decade ago.

"Cancer scientists share the blame," the writers assert. When Weiner asked why the "professional consensus" at NCI is only requesting a $1 billion increase for 2009, AACR expert panelists gave two reasons: "complacency" and a feeling of "the limits of entitlement. Scientists should show the same vision in their funding requests from government as they do in their search for disease cures," the authors argue. "Wouldn't we rather see additional costs for visionary medical cures for cancer than a war causing cancer to our economy?"

Link to printed article: http://www.signonsandiego.com/uniontrib/20080418/news_lz1e18berg.html

Contact: Bob Weiner/Rebecca VanderLinde 301-293-0821 or 202-329-1700


'/>"/>
SOURCE Robert Weiner Associates
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
2. Cavities in Children Reduced Over 60 Percent by New Experimental Chewable Mints
3. The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care
4. New findings show Enbrel significantly reduced levels of C-reactive protein
5. Ovarian cancer risk not affected by alcohol and smoking, but reduced by caffeine
6. Risk of HIV, West Nile Virus, E Coli Transmission May be Reduced Through Improved Blood Screening Methods
7. No need for reduced alcohol consumption in later life
8. Nicotine-Reduced Cigarettes Could Boost Quitting
9. HIV drug resistance risk in mothers reduced by combination of common drugs
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Vitamin A derivative associated with reduced growth in some lung cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group LLC is pleased ... professionals throughout the country. The Guard was specifically designed to handle each element ... training, regulatory updates, and compliance coaching. , In addition to meeting the compliance ...
(Date:2/10/2016)... SAN FRANCISCO, Calif. (PRWEB) , ... February 10, 2016 , ... ... category: Best Water Brand. There were three leading bottled water brand owners that topped ... edge services that enhance connectivity and optimize conversion. The premier brand was Tibet 5100, ...
(Date:2/10/2016)... ... 2016 , ... Ongoing news of the ravages of traumatic brain injury (TBI) ... survey that takes a closer look at cases of TBI being managed by their ... TBI among the aging population, and identifies the challenges associated with their care. , ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Gout is ... and brings pain that is often severe, with intense swelling and redness. It is ... eight million people, but older adults are the most susceptible, according to the February ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association ... inspirational speaker Jan Fox will serve as keynote speaker at the organization’s 2016 ... with tools to more effectively communicate with their own organizational staff and leadership. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 Urologix, the market leader for in-office ... Prostatic Hyperplasia (BPH), announces new private ownership and is ... medical device industry veteran of more than 20 years, ... Plymouth, Minn. The ... and Prostiva® RF Therapy, will continue to be broadly ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: